Argos Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock and Warrants Jul 28, 2016 09:23AM
Roth Boosts PT on Argos Therapeutics (ARGS) to $18; Focus Remains on ADAPT, IDMC Looks Apr 19, 2016 10:56AM
Argos Therapeutics (ARGS) Nearing Complete Enrollment in the Phase III ADAPT Study, Roth Capital Notes May 14, 2015 07:22AM
Roth Capital Starts Argos Therapeutics (ARGS) at Buy Mar 26, 2015 07:29AM